http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102422842-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate | 2020-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102422842-B1 |
| titleOfInvention | Compositon for regulating translation of RNA using CRISPRi |
| abstract | The present invention relates to a CRIPRi technology that targets RNA of a target gene, and the gene expression inhibition/inhibition technology according to the present invention targets RNA and inhibits its function or interferes with translation, unlike the conventional CRISPR protein. Because it inhibits gene expression through It is effective for gene suppression of small regulatory RNA, and has the effect of securing safety because it targets RNA rather than genomic DNA. |
| priorityDate | 2020-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 389.